Brett K. Haumann, SVP Clin Development & Chief Med Ofc at Theravance Biopharma, Inc. (TBPH), sold 14,116 shares at $27.97 ($394K) on 2016-08-19, disclosed to the SEC on 2016-08-23.
Open-market sale of $394k TBPH by SVP Clin Development & Chief Med Ofc. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.97 | 9,509 | $266K | 67.4% |
| 2 | $27.89 | 4,607 | $128K | 32.6% |
| Total | $27.94 avg | 14,116 | $394K | 100% |
| Filing → |
| TBPH | SELL | 2016-08-25 | $126K | — | Filing → |